Report in 12 hours
Booked 0 times
Unconjucated E3
Assessing Hormonal Levels for Comprehensive Reproductive and Endocrine Health Insight
Sample Type
blood
Fasting Required
No
Description
During pregnancy, a healthcare provider may request a series of E3 samples to assess whether there is an increase or decrease in the E3 level over time. Unconjugated E3 is often measured in the second-trimester of pregnancy as part of the triple/quad screen. Usually, to help diagnose any congenital disabilities or monitor a high-risk pregnancy.
Covid Safety
Assured
Free Report
Counselling
Recommended for You
How our test process works!
During pregnancy, a healthcare provider may request a series of E3 samples to assess whether there is an increase or decrease in the E3 level over time. Unconjugated E3 is often measured in the second-trimester of pregnancy as part of the triple/quad screen. Usually, to help diagnose any congenital disabilities or monitor a high-risk pregnancy.
It assess the risk of a pregnant woman carrying a fetus with genetic abnormalities such as Down syndrome, to assess the risk of preterm birth, prenatal diagnosis of steroid metabolism abnormalities in the developing fetus and evaluation of the metabolism of estrogens and pharmaceutical substances with estrogenic action.
40nmol/L at delivery.
A low uE3 level can indicate the possibility of aromatase deficiency, congenital adrenal hyperplasia, primary or secondary (including maternal corticosteroid therapy) fetal adrenal insufficiency and/or fetal demise.
Excessive estrogen levels have been associated with increased risk of some hormonedependent cancers.
Blood
Frequently Asked Question
Unconjugated Estriol (E3) levels, when measured as part of maternal serum screening tests, are used to assess the risk of certain fetal abnormalities rather than provide a definitive diagnosis. Abnormal levels may indicate an increased likelihood of fetal abnormalities, but further diagnostic testing, such as amniocentesis or chorionic villus sampling (CVS), may be recommended for confirmation.
Abnormal Unconjugated Estriol (E3) levels detected during pregnancy may indicate an increased risk of certain fetal abnormalities, but it does not necessarily mean that the baby will have a specific condition. It is important for pregnant women to discuss the results with their healthcare provider, who can provide further guidance and recommendations for additional testing or monitoring as needed.
Unconjugated Estriol (E3) is a type of estrogen hormone produced by the placenta during pregnancy. It is one of the three main estrogens produced by the body, along with estradiol and estrone.
Unconjugated Estriol (E3) levels are measured using a blood test performed on the mother. The blood sample is typically collected during the second trimester of pregnancy, between weeks 15 and 22.
Several factors can influence Unconjugated Estriol (E3) levels during pregnancy, including maternal age, gestational age, maternal weight, maternal health conditions (such as diabetes), and certain medications. It is essential to consider these factors when interpreting test results.
Unconjugated Estriol (E3) testing, when performed as part of routine prenatal care, is often covered by health insurance. However, coverage may vary depending on the specific insurance plan and individual circumstances. It is advisable to check with the healthcare provider and insurance company regarding coverage and any out-of-pocket costs.
Measuring Unconjugated Estriol (E3) levels during pregnancy provides information about the functioning of the placenta and the fetal development. Abnormal levels of Unconjugated Estriol (E3) may indicate an increased risk of certain fetal abnormalities.
Normal ranges for Unconjugated Estriol (E3) levels during pregnancy can vary depending on factors such as gestational age, maternal age, and individual laboratory standards. Generally, levels are interpreted in conjunction with other maternal serum markers, such as alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG).
Unconjugated Estriol (E3) levels are primarily used as part of maternal serum screening tests to assess the risk of fetal abnormalities rather than monitor fetal growth or well-being directly. Other tests, such as ultrasound examinations and fetal monitoring, are
Report in 12 hours
Booked 0 times
Unconjucated E3
Assessing Hormonal Levels for Comprehensive Reproductive and Endocrine Health Insight
Offered by other labs
Sample Type
blood
Fasting Required
No
Description
During pregnancy, a healthcare provider may request a series of E3 samples to assess whether there is an increase or decrease in the E3 level over time. Unconjugated E3 is often measured in the second-trimester of pregnancy as part of the triple/quad screen. Usually, to help diagnose any congenital disabilities or monitor a high-risk pregnancy.
Covid Safety
Assured
Free Report
Counselling